A New Unique Fertility Treatment - International Financial 一个新的独特的生育治疗的国际金融.pptVIP

2009 Forecast Q1 2009 Q2 2009 Q3 2009 Q4 2009 2009 Revenue $ 7,140 $ 89,999 $ 359,930 $ 456,505 $ 913,574 100% Cost of goods 1,692 14,113 50,407 63,746 129,958 14% Gross Margin 5,448 75,886 309,523 392,759 783,616 86% Operating Expenses Salaries Benefits 271,117 303,457 469,483 500,860 1,544,917 169% Travel 98,000 95,000 105,000 105,000 403,000 44% Admin Compliance 152,166 160,499 160,499 160,499 633,663 69% Board Expenses 43,000 40,000 50,000 50,000 183,000 20% FDA Regulatory 6,000 134,000 384,000 384,000 908,000 99% Market, RD Facility 77,500 169,800 85,400 79,406 412,106 45% Total Operating Expenses 647,783 902,756 1,254,382 1,279,765 4,084,686 447% Operating Margin $ (642,335) $ (826,869) $ (944,860) $ (887,006) $ (3,301,070) -361% Headcount 6 9 12 16 16 2010 Forecast Q1 2010 Q2 2010 Q3 2010 Q4 2010 2010 Revenue $ 586,989 $ 747,207 $ 2,208,512 $ 2,831,380 $ 6,374,088 100% Gross Margin 505,016 643,859 2,033,642 2,608,351 5,790,869 91% Operating Expenses 502,915 612,500 627,500 627,500 2,370,415 37% Salaries Benefits 120,000 120,000 120,